Monday, 20 July 2015

Top Pharma News of the day

Delhi High Court has reserved its verdict on a PIL contending that a large number of illegal and unauthorised pathological laboratories are operating in residential areas of the national capital in violation of the city's master plan and environmental norms.


Aurobindo Pharma Ltd has announced that it has received US FDA tentative approval for sildenafil citrate, according to reports.

Apollo Hospitals Enterprise Ltd (AHEL), one of the leading hospital chains in the country, is planning to increase its capacity by around 25%. Currently, the hospital chain has 9,215 beds.

Delhi High Court has reserved its verdict on a PIL contending that a large number of illegal and unauthorised pathological laboratories are operating in residential areas of the national capital in violation of the city's master plan and environmental norms. 

The National Pharmaceutical Pricing Authority’s (NPPA) decision last week to expand the number of drugs under price control by a further 39 drugs has no doubt increased scope of price control but the pharmaceutical industry feels the overarching objective of increasing access to medicines is not being adequately addressed.(Hindu)

No comments:

Post a Comment